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Abstract
Background: Inflammasomes are multi-protein intracellular signaling complexes that have recently been
hypothesized to play a role in the regulation of the inflammation response. We studied associations between
inflammasome-associated cytokines IL-1β and IL-18 in cerebrospinal fluid (CSF) of patients with bacterial meningitis
and clinical outcome, and pneumococcal serotype. In a murine model of pneumococcal meningitis we examined
the pathophysiological roles of two inflammasome proteins, NLRP3 (Nod-like receptor protein-3) and adaptor
protein ASC (apoptosis-associated speck-like protein).
Methods: In a nationwide prospective cohort study, CSF cytokine levels were measured and related to clinical
outcome and pneumococcal serotype. In a murine model of pneumococcal meningitis using Streptococcus
pneumoniae serotype 3, we examined bacterial titers, cytokine profiles and brain histology at 6 and 30 hours after
inoculation in wild-type (WT), Asc and Nlrp3 deficient mice.
Results: In patients with bacterial meningitis, CSF levels of inflammasome associated cytokines IL-1β and IL-18 were
related to complications, and unfavorable disease outcome. CSF levels of IL-1β were associated with pneumococcal
serotype (p<0.001). In our animal model, Asc and Nlrp3 deficient mice had decreased systemic inflammatory
responses and bacterial outgrowth as compared to WT mice. Differences between Asc−/− and WT mice appeared
sooner after bacterial inoculation and were more widespread (lower pro-inflammatory cytokine levels in both blood
and brain homogenate) than in Nlrp3-/-mice. Nlrp3 deficiency was associated with an increase of cerebral neutrophil
infiltration and cerebral hemorrhages when compared to WT controls.
Conclusions: Our results implicate an important role for inflammasome proteins NLRP3 and ASC in the regulation
of the systemic inflammatory response and the development of cerebral damage during pneumococcal meningitis,
which may dependent on the pneumococcal serotype.
Background
Bacterial meningitis is a life threatening infectious dis-
ease of the central nervous system that affects between
2.6 and 6.0 people per 100 000 per year in Europe and
may be up to ten times higher in developing countries.
The most common causative organism of community
acquired bacterial meningitis in adults is Streptococcus
pneumoniae, which is responsible for two-thirds of cases
in Europe and United States [1]. Pneumococcal meningi-
tis has a case fatality rate of 16%-37% and of the survi-
vors 30-52% suffer from neurological sequelae [2,3].
There remains a need for better (adjuvant) therapies, for
which further understanding of underlying pathophysi-
ology is necessary [4].
Recently, several studies have examined the role of
inflammasomes in bacterial meningitis. Inflammasomes
are intracellular multiprotein complexes, belonging to
the family of Nod-like receptors (NLRs) [5-7], and are
triggered by exposure to microbial and endogenous dan-
ger signals such as ATP, changes in K+ concentration,
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oxygen radicals and uric acid released through cell injury
in inflammation. Upon activation, NLRP3 binds to pro-
caspase via adaptor apoptosis-associated speck-like pro-
tein (ASC), which is shared by several inflammasome
types. Procaspase-1 is converted to activated caspase-1,
which subsequently converts interleukins 1beta (IL-1β)
and IL-18 into their active secreted forms [5-7]. Recently
however, caspase-independent proinflammatory activity
of NLRP3 has also been described [8,9]. To date, four
inflammasomes have been characterized, of which
NLRP3 has been the most extensively researched.
Further examination of the role of inflammasomes in
pneumococcal meningitis is of interest for several reasons:
First, inflammasomes are the well established activators of
caspase-1, which has been shown to be elevated in the
cerebral spinal fluid (CSF) of patients with pneumococcal
meningitis compared to non-infected controls [10,11].
Moreover, mice deficient of caspase-1 displayed less severe
inflammation, decreased brain water content and im-
proved clinical score in a pneumococcal meningitis model
[10,12]. Second, IL-1β, which is activated by caspase-1,
has been shown to be elevated in the CSF of children with
pneumococcal meningitis and correlates with disease se-
verity [11], a finding that also has been observed in various
animal models [13-15]. Lastly, several murine models have
demonstrated the importance of NLRP3 in the patho-
physiology of invasive pneumococcal disease [16,17]. Most
notably, a recent study showed that NLRP3 mediates brain
damage in an experimental meningitis model using a sero-
type 2 S. pneumoniae [18].
In this study we measured the CSF levels of in-
flammasome related cytokines IL-1β and IL-18 in a pro-
spective nationwide cohort of community acquired
bacterial meningitis and correlated these to clinical data
and pneumococcal serotype. We then investigated the
role of inflammasome gene NLRP3 and adapter protein
ASC in a murine model of meningitis using serotype 3




In a nationwide prospective cohort study we included
bacterial meningitis patients older than 16 years of age
with positive CSF cultures who were identified by The
Netherlands Reference Laboratory for Bacterial Menin-
gitis (NRLBM) from March 2006 to June 2009. The
NRLBM provided the names of the hospitals where pa-
tients with bacterial meningitis had been admitted 2–6
days previously. The treating physician was contacted,
and informed consent was obtained from all participat-
ing patients or their legally authorized representatives.
Outcome was graded at discharge according to the
Glasgow Outcome Scale, a well-validated instrument
with good interobserver agreement [20]. A score of one
on this scale indicates death; a score of two a vegetative
state; a score of three severe disability; a score of four
moderate disability; and a score of five mild or no disabil-
ity. A favorable outcome was defined as a score of five,
and unfavorable outcome as a score of one to four. The
study was approved by the medical ethical (review) com-
mittee of the Academic Medical Center of Amsterdam.
IL-1β and IL-18 measurements in CSF samples of patients
with bacterial meningitis
We measured IL-1β and IL-18 in the CSF of 289 patients
with bacterial meningitis included in the cohort and 19
controls with luminex® technology using a Milliplex assay
(Millipore, Billerica, MA, USA). CSF from the first diag-
nostic tap was collected, centrifuged and supernatant was
aliquoted and stored at −80°C until analysis. Controls were
patients evaluated for acute headache, without signs of
meningitis and normal CSF findings. In these patients a
subarachnoid hemorrhage was excluded as cause of their
headache by CSF examination. Leftover CSF was collected,
centrifuged and supernatant was stored at −80°C until
analysis.
Mouse model and tissue preparation
A well characterized and previously described murine
model of pneumococcal meningitis was used in this study
[21]. Nlrp3−/− mice with C57BL/6 background (kind gift
of Richard Flavell, Howard Hughes Medical Institute, Yale
University School of Medicine, New Haven, CT, USA) and
Asc−/− mice with C57BL/6 background (kind gift of Fayyaz
Sutterwala, University of Iowa, Iowa City, IA, USA), and
specific pathogen-free C57BL/6 mice (Charles River, Wil-
mington, MN, USA) were weighed, clinically examined,
and scored clinically. Inoculations were performed in sev-
eral rounds, all with male mice aged 8–12 weeks. In each
inoculation round knockout mice and an equal number of
wild-type mice were inoculated with the same bacterial in-
oculum to control for variations between inocula. Experi-
ments were approved by the Institutional Animal Care
and Use Committee of the Academic Medical Center,
Amsterdam, The Netherlands.
Serotype 3 S. pneumoniae (ATCC 6303; American Type
Culture Collection, Rockville, MD, USA) was grown to
mid log phase in 4 hours at 37°C in Todd-Hewitt broth
supplemented with yeast (Difco, Detroit, MI). Pneumo-
cocci were harvested by centrifugation at 4000 rpm for 10
min, and washed twice with sterile isotonic saline. Bacteria
were diluted to a final concentration of 1x106 CFU/ml and
serial ten-fold dilutions were plated on sheep blood agar
plates for quantification.
Mice were inoculated in the cisterna magna under
isoflurane anesthesia with 10 μl saline containing 1×104
CFU (range 0.6×104 – 1.2×104 CFU) of S. pneumoniae or
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sterile saline alone. Twelve mice per group (WT, Nlrp3−/−
and Asc−/−) were inoculated with S. pneumoniae and six
mice per group (WT, Nlrp3−/− and Asc−/−) with sterile sa-
line. After intracisternal inoculation mice were assessed
for neurologic damage as a result of the puncture, which
was not present in any of the mice. At 6 or 30 hours post
infection mice were anesthetized by intraperitoneal injec-
tion of ketamine (Eurovet Animal Health, Bladel, the
Netherlands) and medetomidine (Pfizer Animal Health,
Capelle aan den Ijssel, the Netherlands) followed by car-
diac puncture for blood collection and perfusion of organs
with sterile isotonic saline via the left ventricle.
CSF was collected by puncture of the cisterna magna,
and brains, lungs and spleen were harvested. The right
hemisphere was suspended in 10% buffered formalin and
embedded in paraffin for histopathology. The left hemi-
sphere and spleen were taken up in 20% weight per vol-
ume sterile saline and were disrupted with a tissue
homogenizer. Serial ten-fold dilutions of blood, CSF, brain
homogenate and spleen homogenate were plated on
sheep-blood agar plates and bacteria were allowed to grow
overnight at 37°C. Heparin blood was centrifuged at 4000
rpm for 5 min. at 4°C. Tissue homogenates were lysed by
adding 1:1 two times concentrated lysis buffer (150 mM
NaCl, 15 mM Tris, 1 mM MgCl(H2O)6, 1 mM CaCl2
(H2O)2, 1% Triton, AEBSF 4 μg/ml, EDTA-NA2 50 μg/ml,
pepstatin 10 ng/ml, leupeptin 10 ng/ml, pH 7.4), incubat-
ing on ice for 30 min. and centrifuged at 4000 rpm for 5
min. at 4°C. Plasma and lysed tissue supernatant were re-
moved and stored at −20°C for further analysis.
RT-PCR
Total RNA was isolated from murine brain homogenates
with the Nucleospin® RNA II Purification kit (Clontech La-
boratories, Mountain View, CA, USA; Bioke, Leiden, the
Netherlands). Isolated RNA was converted to cDNA using
oligo(dT) primer (Promega, Leiden, the Netherlands),
Moloney murine leukemia virus reverse transcriptase
(Invitrogen, Breda, the Netherlands), RT-buffer (Promega,
Leiden, the Netherlands), deoxynucleotide triphosphate
mix (Invitrogen, Breda, the Netherlands), dithiothreitol
(Duchefa Farma, Haarlem, the Netherlands) and RNAse in-
hibitor (Invitrogen, Breda, the Netherlands). After incuba-
tion for 10 min at 23°C, RT was carried out for 60 min at
42°C, followed by RT inactivation for 3 min at 95°C. Re-
verse transcription-PCR’s (RT-PCRs) were performed with
LightCycler SYBR green I master mix (Roche, Mijdrecht,
the Netherlands) and measured in a LightCycler 480
(Roche) apparatus under the following conditions: 5 min
95°C hot start, followed by 40 cycles of amplification (95°C
for 15 sec - 60°C for 5 sec - 72°C for 20 sec). For quantifica-
tion, standard curves were constructed on serial dilutions
of a sample with known high cDNA content. Data were an-
alyzed using LightCycler software. Gene expression is
presented as a ratio of the expression of the housekeep-
ing gene Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). The primers used for RT-PCR were as follows:
mouse GAPDH, 5'-CTCATGACCACAGTCCATGC-3'
(forw) and 5'-CACATTGGGGGTAGGAACAC-3' (rev);
mouse Nlrp3, 5'-CCACAGTGTAACTTGCAGAAGC-3'
(forw) and 5'- GGTGTGTGAAGTTCTGGTTGG-3' (rev);
mouse Asc, 5'-GGTGTGTGAAGTTCTGGTTGG-3'
(forw) and 5'-GGTGTGTGAAGTTCTGGTTGG-3' (rev).
Cytokine measurements in murine tissue
IL-1β, IL-6, KC, TNF-α, IL-18, and MIP-2 were measured
in plasma and brain homogenates with luminex® technol-
ogy using a mouse cytokine and chemokine Bioplex kit
(Bio-Rad Laboratories, Veenendaal, The Netherlands).
Luminex assays were analysed on a Luminex 200 with
Bio-Plex Manager software 5.0. Samples were 4 times di-
luted. Mouse myeloperoxidase (MPO) was measured by
ELISA (Hycult Biotechnology, Uden, The Netherlands).
Mouse albumin was measured by ELISA (GenWay Bio-
tech, San Diego, CA).
Murine histopathology
Five μm paraffin brain sections were cut in a coronal
plane from the olfactory bulb to the beginning of the
cerebellum, and sections at intervals of 1400 μm or in-
tervals of 700 μm throughout the hippocampal region
were selected. Sections were mounted on slides and
stained with hematoxylin and eosin. To assess differ-
ences in brain damage, coronal cut brain sections of WT
and Asc−/− and Nlrp3−/− mice were scored for intracere-
bral hemorrhages, subpial hemorrhages, cerebral infarc-
tions, and for neutrophil influx on a five point scale: 0)
normal histopathology; 1) few inflammatory cells in the
meninges but no perivascular cuffing; 2) moderate num-
ber of inflammatory cells in the meningitis and cuffing of
some of the vessels; 3) extensive number of inflammatory
cells in the meninges, prominent perivascular cuffs with
mild infiltration of the neutrophil; 4) extensive number of
inflammatory cells in the meninges, prominent perivascu-
lar cuffs, the presence of many inflammatory cells in the
neutrophil and intraparenchymal pocket formation. Sec-
tions of mice 30 hours after induction of pneumococcal
meningitis (n=8 per group) were scored. Sections were
scored by two independent observers blinded for the ex-
perimental groups (interobserver kappa 0.75).
Statistics
The Mann–Whitney U test was used to identify differences
in baseline characteristics, bacterial outgrowth, cytokine
levels and histopathological scores among groups with re-
spect to continuous variables. Dichotomous variables were
compared using the χ2 test. Correlation analyses were
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performed with the Spearman’s rank correlation coefficient.
For all analyses a P-value < 0.05 was considered significant.
Results
CSF IL-1β and IL-18 levels in patients with bacterial
meningitis are associated with complications and
unfavorable disease outcome
A total of 801 Dutch patients with bacterial meningitis
were included as described previously [22]. In this study
the distribution of causative organisms was: 576 episodes
(72%) S. pneumoniae, 92 (12%) Neisseria meningitidis,
41 (5%), Listeria monocytogenes, and other bacteria in 92
(12%) episodes. The case fatality rate was 18%, and 38%
of patients had poor clinical functional outcome as de-
fined as a score of 1–4 on the Glasgow Outcome Scale.
CSF was available in 289 of the episodes with bacterial
meningitis (36%), and 211 of 576 with pneumococcal
meningitis (35%). Levels of IL-1β and IL-18 were ele-
vated in the CSF of patients with meningitis as com-
pared to controls. Higher IL-1β levels were associated
with occurrence of systemic complications (median 0.91
ng/ml [IQR 0.15-3.00] versus 2.02 ng/ml [IQR 0.33-
5.26], p=0.001) and neurologic complications (median
0.81 ng/ml [IQR 0.15-3.36] versus 1.60 ng/ml [IQR 0.29-
4.73], p=0.020). IL-1β levels were higher in patients with
an unfavorable outcome although this difference was not
statistically significant (median 1.04 ng/ml [IQR 0.17-
3.65] versus 1.53 ng/ml [IQR 0.27-5.16], p=0.11). High
IL-18 levels were also associated with systemic complica-
tions (median 8.50 ng/ml [IQR 3.07-20.71] versus 15.13
ng/ml [IQR 6.35-27.32], p=0.006) and unfavorable out-
come (median 9.27 ng/ml [IQR 3.36-22.83] versus 14.65
ng/ml [IQR 5.53-26.97], p=0.037). In the subgroup of
patients with pneumococcal meningitis (n=211) associa-
tions with systemic complications remained significant.
CSF IL-1β and IL-18 levels in patients with bacterial
meningitis are associated with pneumococcal serotype
Pneumococcal serotyping was performed in 509
pneumococcal strains (88%) and the most common sero-
types were 3, 23 and 7 (Table III; serotype distribution
has been partly published previously [23]). CSF levels of
IL-1β were related to pneumococcal serotype (Kruskal-
Wallis 1 way ANOVA, p<0.001; Figure 1).
ASC and NLRP3 expression in Asc and Nlrp3 knockout
mice
To confirm that the inflammasome components ASC and
NLRP3 were expressed or knocked out in our meningitis
mouse model, we examined mouse brain homogenates
from WT mice infected with S. pneumoniae serotype 3. At
6 and 30 h after infection ASC and NLRP3 expression in
brain homogenates appeared upregulated as compared to
saline inoculated mice (Figure 2). Nlrp3−/− mice showed
expression of ASC and no NLRP3, and conversely Asc−/−
mice showed expression of NLRP3 and no ASC.
Decreased systemic bacterial loads in Asc and Nlrp3
knockout mice
Nlrp3−/− mice showed more bacterial outgrowth in CSF
at 6 h compared to WT mice (median 9.2 x 105 CFU/ml
versus 2.2 x 105 CFU/ml, p=0.046 Figure 3A). However,
Nlrp3−/− had less bacterial outgrowth in blood and
spleen at 30 h, as compared to WT mice (blood, 5.7 ×
103 CFU/ml versus 3.2 × 104 CFU/ml, p=0.017; spleen,
8.0 × 103 CFU/ml versus 4.7 × 105 CFU/ml, p=0.012
Figure 3B). No differences in bacterial outgrowth in
brain homogenates were observed. Asc−/− mice showed
less bacterial outgrowth at 6 h in blood and lung
compared to WT mice (blood, 2.0 × 103 CFU/ml versus
6.6 × 103 CFU/ml, p=0.017; lung, 2.0 × 103 CFU/ml ver-
sus 1.1 × 105 CFU/ml, p=0.043 Figure 3C). At 30 h Asc−/−
mice showed less bacterial outgrowth in blood (3.9 x 104
CFU/ml versus 1.4 × 105 CFU/ml, p=0.039 Figure 3D) and
spleen (3.1 × 104 CFU/ml versus 6.7 × 104 CFU/ml,
p=0.016). No differences in bacterial outgrowth in CSF or
brain homogenates in Asc−/− mice were observed.
Decreased systemic inflammatory response in both Nlrp3
and Asc knockout mice at 6 and 30 hrs
Nlrp3−/− mice showed decreased plasma levels of MIP-2
(median 12 pg/ml [IQR 5–20] versus 55 pg/ml [IQR 5–
77], p=0.037) and IL-6 (52 pg/ml [IQR 24–90] versus
191 pg/ml [70–306], p=0.019) at 30 h as compared to
WT mice (Figure 4A). No significant cytokine differ-
ences were found at 6 hours. Asc−/− mice showed de-
creased plasma levels of MIP-2 (12 pg/ml [IQR 5–27]
versus 55 pg/ml [IQR 35–80] pg/ml, p=0.01), IL-6 (37
pg/ml [IQR 24–108] versus 202 pg/ml [IQR 46–448],
p=0.034) and IFN- γ (3 pg/ml [3] versus 16 pg/ml
[3-24], p=0.005) at 30 h, as compared to WT mice. At 6
h only KC levels were lower (105 pg/ml [78–202] versus
186 pg/ml [151–388], p=0.005). Notably, plasma levels
of IL-1β and IL-18 were similar in Nlrp3−/−, Asc−/− and
WT mice (Figure 4C). For the other measured cytokines
no significant difference was found at 6 or 30 hours.
Decreased brain cytokine and chemokine levels in Asc−/−
but not Nlrp3−/− mice
Nlrp3−/− mice showed no differences in cytokine re-
sponses in the brain compared to WT mice, and brain al-
bumin levels were also similar between WT and Nlrp3−/−
mice (data not shown). Asc−/− mice displayed lower levels
of KC (median, 3.81 ng/ml [IQR 1.57-11.24] versus 16.75
ng/ml [IQR 11.49-18.12], p=0.040), MIP-2 (7.74 ng/ml
[IQR 1.46-8.91] vs. 9.74 ng/ml [IQR 8.20-11.3], p=0.049)
and IL-6 (0.30 ng/ml [IQR 0.10-0.45] versus 0.76 ng/ml
[IQR 0.61-1.45], p=0.049) than WT mice in brain
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homogenates at 30 h (Figure 4D). Consistent with this find-
ing, brain albumin concentrations were decreased in Asc−/−
mice compared to WT mice at 30 h (p=0.026), indicating
attenuated blood brain barrier disruption in Asc−/− mice
compared to WT mice. No differences in brain IL-1β or
IL-18 levels were measured between WT and Nlrp3−/− or
Asc−/− mice.
Enhanced brain damage in Nlrp3−/− but not in Asc−/− mice
Neutrophil infiltrate in the brain was more pronounced in
Nlrp3−/− mice at 30 h after inoculation as compared to WT
mice (median score 1.5 versus 2.4, p=0.018; Figure 5G).
Nlrp3−/− mice also showed an elevated number of intrace-
rebral and subpial hemorrhages and as compared to WT
mice (median 12.5 versus 1.0 per slide, p=0.02; Figure 5H).
Asc−/− mice showed no difference in neutrophil influx score
and intracerebral hemorrhages compared to WT mice.
Brain MPO levels were similar in both knockouts and wild-
type mice (data not shown).
Discussion
This study implicates an important role for inflammasomes
in regulation of systemic inflammation and development of
cerebral damage during pneumococcal meningitis. In our
patient cohort, inflammasome associated cytokines IL-1β
and IL-18 levels in CSF of patients with bacterial meningitis
correlated with development of systemic complications and
unfavorable prognosis; and in the subgroup of patients with
pneumococcal meningitis, IL-1β and IL-18 correlated with
systemic complications only. In our murine model of
pneumococcal meningitis, deficiency of inflammasome
components ASC and NLRP3 led to decreased systemic in-
flammatory responses and bacterial outgrowth in the
systemic compartment as compared with WT mice. Con-
versely, Nlrp3 deficiency led to enhanced central nervous
system inflammation and increased brain damage. Differ-
ences between Asc−/− and WT mice occurred sooner after
intrathecal inoculation with S. pneumoniae (lower bacterial
titers and KC serum levels at 6 h) and were more wide-




















































Figure 1 Median levels of IL-1β (A) and IL-18 (B) with interquartile range by pneumococcal serotype. CSF levels of IL-1β and IL18 were
related to pneumococcal serotype (Kruskal-Wallis 1 way ANOVA, p<0.001).
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systemic compartment (blood) and central nervous system
compartment (brain homogenate)) than in the Nlrp3-/-
mice.
In our murine model, NLRP3 was protective for brain
damage, as Nlrp3−/− mice had enhanced cerebral neutro-
phil influx and an increased number of cerebral hemor-
rhages. NLRP3 has been investigated with regard to
pneumococcal infections in both lung infection models
and a meningitis model [17,18,24], but findings are not
unanimous. In a lung-infection model, Nlrp3−/− mice
have higher bacterial titers and a higher mortality than
WT controls. In a murine model of pneumococcal men-
ingitis, better clinical outcome and decreased brain in-
flammation in Nlrp3−/− (and Asc−/−) mice was found as
compared to WT controls [18]. Blocking of IL-1β and
IL-18 in this meningitis model, led to a decrease in dis-
ease severity and which prompted the suggestion that
the NLRP and ASC dependent changes are solely IL-1
Figure 3 Bacterial outgrowth in blood, spleen, lung brain and CSF. Bacterial titers in WT vs., Nlrp3−/− mice at 6 (A) and 30 hours (B); and WT
vs. and Asc−/− mice at 6 (C) and 30 hours (D) after induction of pneumococcal meningitis. Twelve mice per group were analyzed. Data are given
as medians and 75th quartile. * P < 0.05.
Figure 2 Expression of NLRP3 and ASC in brain homogenates. Expression of NLRP3/GAPDH (A) and ASC/GAPDH (B) in brain homogenates
of WT, Asc−/− and Nlrp3−/− mice 6 hours and 30 hours after induction of S. pneumoniae meningitis compared to mice inoculated with saline.
Three mice per group were analysed in the sham infected mice and the 6 hour timepoint; 4 mice were analyzed at the 30 hour timepoint.
Data are given as means +/− SD.
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and IL-18 related [18]. Our findings that IL-1β and IL-
18 levels were not significantly altered in Nlrp3−/− or
Asc−/− mice, must be interpreted with caution as no as-
says are available that can discriminate between the pro-
and active forms of murine IL-1β and IL-18. Previous
studies showed increased IL-1β levels in brain homoge-
nates of WT mice with pneumococcal meningitis at 30
hours compared to sham [21]. We did not perform ex-
periments blocking IL-1β, IL-18 or Caspase-1 in our
model to further elucidate this mechanism.
Discrepancies in brain damage in Nlrp3−/− mice be-
tween our study and the previous study in experimental
pneumococcal meningitis may be explained by the differ-
ent pneumococcal serotypes used to establish meningitis
between both models [18]. We inoculated mice with a S.
pneumoniae serotype 3 strain as opposed to the serotype 2
strain used in the previous study. Furthermore, we used a
lower intrathecal dose of S. pneumoniae than the previous
study (104 CFU vs. 105/106 CFU). S. pneumoniae serotype
2 is less heavily encapsulated and less virulent than sero-
type 3 and needs high doses to induce infection [25]. An
in vitro study showed that high bacterial loads of S.
pneumoniae serotype 2 are needed before IL-1β concen-
tration in cell culture supernatants are elevated [26].
The variation of immune response between different
serotypes of S. pneumoniae has been demonstrated by
several groups [25,27]. In our patient cohort, we ob-
served that the most common pneumococcal serotypes
were 3, 23, and 7, and that CSF levels of IL-1β was sero-
type related. This observation may be due to serotype
specific properties of the pneumococcal capsule. Alterna-
tively, pneumolysin, a pore-forming toxin which is known
to interact directly with the innate immune system
(through, for instance complement or binding of Toll Like
Receptor-4), is secreted in varying amounts depending on
bacterial serotype. Pneumolysin has been reported to have
both inflammasome inhibiting and activating properties
[16,17,28], which may be caused by the recently described
effects of pneumolysin polymorphisms on innate immune
system recognition [17]. We chose S. pneumoniae sero-
type 3 for our animal studies, as it is one of the most com-
monly encountered serotypes among patients with
pneumococcal meningitis [19].
The more pronounced phenotype of the Asc−/− mice as
compared to the Nlrp3−/− mice with pneumococcal men-
ingitis can be explained by other, NLRP3 inflammasome
independent, functions of ASC. The (functional) relation-
ship between ASC, NLRP3, and caspase-1 activation dur-
ing pneumococcal infection was recently described in
murine pneumonia model [24], in which S. pneumoniae
infection led to caspase-1 activation and IL-1β/IL-18 mat-
uration through the activation of both the NLRP3 and the
AIM2 (absent in melanoma) inflammasomes, in a process
which was completely absent in the ASC deficient mice.
Furthermore, ASC is capable of binding and facilitating
the function of several other inflammasomes (such as
Figure 4 Cytokine levels in blood and brain homogenate. Cytokines were measured in WT (n = 11), Nlrp3−/− (n = 12) and Asc−/− (n = 12)
mice in blood (A, C) and brain homogenate (WT; n = 7, Nlrp3−/−; n = 8, Asc−/−; n = 8) (B, D) at 30 hours after induction of pneumococcal
meningitis. Undisplayed cytokines measurement did not differ significantly between Nlrp3−/− or Asc−/− and WT mice. Data are given as medians
and 75th quartile. * P < 0.05.
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NLRC4 and IFI16), though the relevance of this during
pneumococcal infection is not evident [29]. Lastly, inde-
pendently of the inflammasomes, ASC has been shown to
potent regulator of a large number of inflammatory and
cell-death related genes [30]. The observation that NLRP3
deficient mice but not ASC deficient mice, expressed more
brain damage suggests a protective mechanism in which
NLRP3 may act independently of ASC and of the NLRP3
inflammasome. Such “inflammasome-independent” role of
NLRP3 in tissue injury has been described in a mouse
model of renal ischemia-reperfusion injury [8,9], though a
mechanism remains unclear.
Conclusion
In conclusion, although a definite mechanism remains elu-
sive, our results provide additional evidence for an import-
ant role of inflammasomes (specifically the NLRP3 and
ASC proteins and inflammasome associated cytokines IL-
1β and IL-18) in the regulation of an inflammatory re-
sponse and brain damage during pneumococcal meningitis.
Further human and animal studies are necessary to clarify
the pathophysiological mechanism, as well as explore the
possibility of interference of inflammasome activation as a
potential adjunctive therapy in the treatment of pneumo-
coccal meningitis.
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